Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;1(2):107-14.
doi: 10.1177/1756287209104830.

Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors

Affiliations

Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors

Thomas J Guzzo et al. Ther Adv Urol. 2009 Jun.

Abstract

Objectives: Open retroperitoneal lymph node dissection has been traditionally used for the management of patients with nonseminomatous germ-cell tumors (NSGCTs). Over the last decade, laparoscopic retroperitoneal lymph node dissection (LRPLND) has gained popularity in several highly specialized centers.

Methods: We retrospectively reviewed the English-language literature with regard to LRPLND. The perioperative and oncologic outcomes for patients with low stage NSGCTs who underwent LRPLND are summarized in this review with particular emphasis on contemporary studies.

Results: Initially only used for staging, LRPLND has evolved to a therapeutic procedure capable of replicating the templates used for open RPLND. Perioperative outcomes including operative time, conversion rates and complications improve with surgeon experience and are acceptable at high volume centers. Oncologic outcomes are promising, but require longer term follow-up and the administration of adjuvant chemotherapy in many studies limits comparison to that of the open technique.

Conclusion: LRPLND has been demonstrated to be feasible and safe at large volume institutions with experienced laparoscopic surgeons. LRPLND was originally performed as a staging procedure in patients with NSGCTs but has evolved into a therapeutic operation with early reports demonstrating short hospital stays and minimal morbidity. Further studies in larger cohorts of patients with longer term follow up are required to define the exact role of LRPLND.

Keywords: laparoscopic retroperitoneal lymph node dissection; testicular cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
LRPLND is performed with patient supine on operating room table and both arms tucked. Supine positioning allows for easy conversion to full bilateral LRPLND when warranted.
Figure 2
Figure 2
Portion of right template LRPLND illustrating renal hilum superiorly, right ureter laterally and inferior vena cava medially.
Figure 3
Figure 3
Interaortocaval lymph node dissection, with transection of lumbar vein to allow access to retrocaval nodes.
Figure 4
Figure 4
Portion of left-sided nerve sparing template illustrating preserved sympathetic nerve fibers, renal hilum superiorly, left ureter laterally and aorta medially.

Similar articles

Cited by

References

    1. Abdel-Aziz K.F., Anderson J.K., Svatek R., Marqulis V., Saqalowsky A.I., Cadeddu J.A. (2006) Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors. J Endourol 20: 627–631 - PubMed
    1. Albqami N., Janetschek G. (2005) Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol 19: 683–692 - PubMed
    1. Baniel J., Foster R.S., Gonin R., Messemer J.E., Donohue J.P., Einhorn L.H. (1995) Late relapse of testicular cancer. J Clin Oncol 13: 1170–1176 - PubMed
    1. Bhayani S.B., Ong A., Oh W.K., Kantoff P.W., Kavoussi L.R. (2003) Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology 62: 324–327 - PubMed
    1. Carver B.S., Sheinfeld J. (2005) Germ cell tumors of the testis. Ann Surg Oncol 12: 871–880 - PubMed

LinkOut - more resources